J. Biollaz

发表

Renal Effects of Nimesulide in Furosemide-Treated Subjects

F. Steinhäuslin, A. Munafo, T. Buclin, 2012, Drugs.

Imatinib metabolite profiling in parallel to imatinib quantification in plasma of treated patients using liquid chromatography-mass spectrometry.

J. Biollaz, L. Decosterd, B. Rochat, 2008, Journal of mass spectrometry : JMS.

Population Pharmacokinetics of Atazanavir in Patients with Human Immunodeficiency Virus Infection

A. Telenti, T. Buclin, J. Biollaz, 2006, Antimicrobial Agents and Chemotherapy.

Population Pharmacokinetics of Indinavir in Patients Infected with Human Immunodeficiency Virus

A. Telenti, T. Buclin, J. Biollaz, 2004, Antimicrobial Agents and Chemotherapy.

Model‐based meta‐analysis of salbutamol pharmacokinetics and practical implications for doping control

T. Buclin, J. Biollaz, Perrine Courlet, 2022, CPT: pharmacometrics & systems pharmacology.

Sequential administration of temozolomide and fotemustine: depletion of O6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours.

J. Biollaz, L. Perey, C. Marzolini, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration

T. Buclin, J. Biollaz, C. Marzolini, 1998, Cancer Chemotherapy and Pharmacology.

Pharmacokinetic Optimisation of Angiotensin Converting Enzyme (ACE) Inhibitor Therapy

J. Biollaz, M. Burnier, 1992, Clinical Pharmacokinetics.

Antihypertensive Therapy with MK 4211: Angiotensin II‐Renin Relationships to Evaluate Efficacy of Converting Enzyme Blockade

J. Biollaz, H. Gavras, B. Waeber, 1982, Journal of cardiovascular pharmacology.

Hypertensive crisis treated with orally administered captopril

J. Biollaz, B. Waeber, H. Brunner, 2004, European Journal of Clinical Pharmacology.

Effect of dronedarone on renal function in healthy subjects

T. Buclin, J. Biollaz, L. Decosterd, 2005, British journal of clinical pharmacology.

Effect of dronedarone on renal function in healthy subjects

T. Buclin, J. Biollaz, L. Decosterd, 2005, British Journal of Clinical Pharmacology.

Influence of hypobaric hypoxia on leptin levels in men

J. Biollaz, M. Tschöp, H. Hautmann, 2000, International Journal of Obesity.

NAT2 and CYP1A2 phenotyping with caffeine: head-to-head comparison of AFMU vs. AAMU in the urine metabolite ratios.

T. Buclin, J. Biollaz, L. Decosterd, 2003, British journal of clinical pharmacology.

Extractionless method for the simultaneous high-performance liquid chromatographic determination of urinary caffeine metabolites for N-acetyltransferase 2, cytochrome P450 1A2 and xanthine oxidase activity assessment.

J. Biollaz, L. Decosterd, U. Kesselring, 2001, Journal of chromatography. B, Biomedical sciences and applications.

Diet Acids and Alkalis Influence Calcium Retention in Bone

T. Buclin, J. Biollaz, L. Decosterd, 2001, Osteoporosis International.

Grand mal seizure after extradural morphine analgesia.

J. Biollaz, A. Borgeat, B. Depierraz, 1988 .

A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma.

J. Keiser, J. Biollaz, L. Decosterd, 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects.

J. Biollaz, M. Burnier, B. Waeber, 1995, Hypertension.

Population Pharmacokinetics of Ganciclovir in Solid-Organ Transplant Recipients Receiving Oral Valganciclovir

T. Buclin, J. Biollaz, L. Decosterd, 2009, Antimicrobial Agents and Chemotherapy.

Nelfinavir Plasma Levels Under Twice-Daily and Three-Times-Daily Regimens: High Interpatient and Low Intrapatient Variability

A. Telenti, T. Buclin, J. Biollaz, 2001, Therapeutic drug monitoring.

Influence of food and antacid administration on fluoride bioavailability from enteric-coated sodium fluoride tablets.

J. Biollaz, M. Chapuy, P. Meunier, 1989, Bone.

Effect of population-based screening on breast cancer mortality

J. Biollaz, P. Nicot, J. Spinosa, 2012, The Lancet.

Site of the action of a synthetic atrial natriuretic peptide evaluated in humans.

J. Biollaz, F. Brunner‐Ferber, B. Waeber, 1987, Kidney international.

Estimation of glomerular filtration rate by sinistrin clearance using various approaches.

T. Buclin, J. Biollaz, L. Decosterd, 1998, Renal failure.

Escape from mineralocorticoid excess: the role of angiotensin II.

J. Biollaz, H. Gavras, H. Brunner, 1982, The Journal of clinical endocrinology and metabolism.

Hormonal, global, and regional haemodynamic responses to a vascular antagonist of vasopressin in patients with congestive heart failure with and without hyponatraemia.

J. Biollaz, M. Schaller, J. Goy, 1986, British heart journal.

Infusion of Atrial Natriuretic Peptide to Patients with Congestive Heart Failure

V. Mooser, J. Biollaz, J. Goy, 1988, Journal of Cardiovascular Pharmacology.

Pharmacokinetic-Pharmacodynamic Profile of Angiotensin II Receptor Antagonists

T. Buclin, J. Biollaz, C. Csajka, 1997, Clinical pharmacokinetics.

Determination of Trace Lithium in Human Erythrocytes by Electrothermal Atomic‐absorption Spectrometry with Pyrocoated Graphite Tubes and Integrated Platform

T. Buclin, J. Biollaz, L. Decosterd, 1998, The Journal of pharmacy and pharmacology.

Prevention of arrhythmias after noncardiac thoracic operations: flecainide versus digoxin.

A. Munafo, J. Biollaz, A. Borgeat, 1991, The Annals of thoracic surgery.

Lack of angiotensin I accumulation after converting enzyme blockade by enalapril or lisinopril in man.

J. Biollaz, B. Waeber, J. Nussberger, 1987, Clinical science.

Characterization of the angiotensin II receptor antagonist TCV-116 in healthy volunteers.

J. Biollaz, B. Waeber, E. Delacrétaz, 1995, Hypertension.

The clinical application of converting enzyme inhibitors.

J. Biollaz, B. Waeber, J. Nussberger, 1983, Clinical and experimental hypertension. Part A, Theory and practice.

Population Pharmacokinetic-Pharmacodynamic Modelling of Angiotensin Receptor Blockade in Healthy Volunteers

T. Buclin, J. Biollaz, C. Csajka, 2002, Clinical pharmacokinetics.

Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist

Y. Christen, A. Munafo, J. Biollaz, 1992, Clinical pharmacology and therapeutics.

Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.

T. Buclin, J. Biollaz, L. Decosterd, 1999, Journal of hypertension.

Validation of an HPLC method for the determination of urinary and plasma levels of N1-methylnicotinamide, an endogenous marker of renal cationic transport and plasma flow.

J. Biollaz, L. Decosterd, U. Kesselring, 2001, Journal of pharmaceutical and biomedical analysis.

Determination of trace lithium in biological fluids using graphite furnace atomic absorption spectrophotometry: variability of urine matrices circumvented by cation exchange solid phase extraction.

J. Biollaz, L. Decosterd, C. Centeno, 1996, Pharmaceutica acta Helvetiae.

Fractional excretion of trace lithium and uric acid in acute renal failure.

F. Steinhäuslin, A. Munafo, T. Buclin, 1994, Journal of the American Society of Nephrology : JASN.

A Review of its Pharmacology and Therapeutic Potential in the Management of Glaucoma and Ocular Hypertension

J. Biollaz, I. Goldberg, Y. Kitazawa, 1997 .

Renal function tests in experimental toxicity studies.

J. Biollaz, J. Diezi, 1979, Pharmacology & therapeutics. Part B: General & systematic pharmacology.

Renal sodium handling in patients with untreated hypertension and white coat hypertension.

J. Biollaz, M. Burnier, H. Brunner, 1994, Hypertension.

Bioavailability of repeated oral administration of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase in healthy volunteers

T. Buclin, J. Biollaz, F. Brunner‐Ferber, 2000, European Journal of Clinical Pharmacology.

Effects of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase on the vasopressor response to exogenous angiotensin I and angiotensin II challenges in healthy volunteers.

T. Buclin, J. Biollaz, F. Brunner‐Ferber, 1998, Journal of cardiovascular pharmacology.

Ambulatory blood pressure recording to identify hypertensive patients who truly need therapy.

J. Biollaz, M. Schaller, B. Waeber, 1984, Journal of chronic diseases.

Dose-dependent effect of atrial natriuretic peptide on blood pressure, heart rate, and skin blood flow of normal volunteers.

J. Biollaz, F. Brunner‐Ferber, B. Waeber, 1986, Journal of cardiovascular pharmacology.

Atrial natriuretic peptide and urinary prostaglandins in man.

J. Biollaz, B. Waeber, J. Sassard, 1989, British journal of clinical pharmacology.

Vasopressin Blood Pressure Dependency after α-Adrenoceptor Blockade in Normotensive and Mineralocorticoid-Salt Hypertensive Rats

J. Biollaz, M. Burnier, H. Gavras, 1982 .

Comparison in normal volunteers of three converting enzyme inhibitors: RHC 3659, MK 421 and captopril.

J. Biollaz, M. Burnier, H. Gavras, 1982, American Journal of Cardiology.

Determination of imatinib (Gleevec) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detection.

T. Buclin, J. Biollaz, L. Decosterd, 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Effect of oral triiodothyronine during amiodarone treatment for ventricular premature complexes.

J. Biollaz, J. Goy, P. Nicod, 1986, The American journal of cardiology.

Molecular and clinical determinants of drug-induced long QT syndrome: an iatrogenic channelopathy.

T. Buclin, J. Biollaz, J. Schläpfer, 2004, Swiss medical weekly.

HEMODYNAMIC, RENAL, AND ENDOCRINE EFFECTS OF 4‐ H INFUSIONS OF HUMAN ATRIAL NATRIURETIC PEPTIDE IN NORMAL VOLUNTEERS

J. Biollaz, G. Waeber, B. Waeber, 1988, Fundamental & clinical pharmacology.

Sodium chloride-induced partial inhibition in vivo of alpha 2-adrenoceptor agonist function.

J. Biollaz, H. Gavras, I. Gavras, 1985, Journal of hypertension.

Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction.

A. Telenti, T. Buclin, J. Biollaz, 2000, Journal of chromatography. B, Biomedical sciences and applications.

A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine.

A. Telenti, H. Günthard, T. Buclin, 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Spectrophotometric determination of methylene blue in biological fluids after ion-pair extraction and evidence of its adsorption on plastic polymers

T. Buclin, J. Biollaz, L. Decosterd, 1997 .

Mechanism of Action of Vasodilating Agents

A. Munafo, T. Buclin, J. Biollaz, 1988 .

Transplacental passage of protease inhibitors at delivery

A. Telenti, T. Buclin, J. Biollaz, 2002, AIDS.

Atrial natriuretic peptides: Reproducibility of renal effects and response of liver blood flow

J. Biollaz, F. Brunner‐Ferber, B. Waeber, 2004, European Journal of Clinical Pharmacology.

Clinical pharmacology of atrial natriuretic (3-28) eicosahexapeptide.

J. Biollaz, B. Waeber, J. Nussberger, 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Pharmacokinetics of synthetic atrial natriuretic peptides in normal men

J. Biollaz, B. Waeber, J. Nussberger, 1987, Clinical pharmacology and therapeutics.

The renal effects of clonidine in unanesthetized rats.

J. Atkinson, J. Biollaz, F. Roch-Ramel, 1979, European journal of pharmacology.

Orosomucoid (α1‐acid glycoprotein) plasma concentration and genetic variants: Effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation

A. Telenti, T. Buclin, J. Biollaz, 2006, Clinical pharmacology and therapeutics.

Trimethoprim, alone or in combination with sulphamethoxazole, decreases the renal excretion of zidovudine and its glucuronide.

F. Steinhäuslin, A. Munafo, J. Biollaz, 1992, British journal of clinical pharmacology.

Raised leptin concentrations at high altitude associated with loss of appetite

J. Biollaz, M. Tschöp, C. Strasburger, 1998, The Lancet.

Effects of the new oral angiotensin converting enzyme inhibitor MK-421 in human hypertension.

J. Biollaz, H. Gavras, R. Davies, 1982, Clinical and experimental hypertension. Part A, Theory and practice.

Ritonavir-Boosted Atazanavir-Lopinavir Combination: A Pharmacokinetic Interaction Study of Total, Unbound Plasma and Cellular Exposures

A. Telenti, T. Buclin, J. Biollaz, 2006, Antiviral therapy.

Circadian variations of renal sodium handling in patients with orthostatic hypotension.

J. Biollaz, M. Burnier, E. Grouzmann, 1998, Kidney international.

Lithium Infusion to Study Sodium Handling in Unanesthetized Hypertensive Rats

J. Biollaz, M. Burnier, B. Waeber, 1986, Hypertension.

Absence of metabolic effects of the topical carbonic anhydrase inhibitors MK‐927 and sezolamide during two‐week ocular administration to normal subjects

A. Munafo, T. Buclin, J. Biollaz, 1991, Clinical pharmacology and therapeutics.

Tolerability and pharmacokinetics of L-648,051. A leukotriene D4-receptor antagonist, in healthy volunteers

J. Biollaz, P. Leuenberger, A. Jaeger, 2004, European Journal of Clinical Pharmacology.

Misleading tacrolimus concentration value in blood taken from a catheter used for tacrolimus administration.

T. Buclin, J. Biollaz, E. Grouzmann, 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Grand mal seizure after extradural morphine analgesia.

J. Biollaz, A. Borgeat, B. Depierraz, 1988, British journal of anaesthesia.

Are Plasma Levels Valid Surrogates for Cellular Concentrations of Antiretroviral Drugs in HIV-infected Patients?

A. Telenti, T. Buclin, J. Biollaz, 2006, Therapeutic drug monitoring.

Lactitol: Gastrointestinal absorption and effect on blood lactate in healthy volunteers and patients with cirrhosis

J. Biollaz, J. Llull, B. Lauterburg, 2004, European Journal of Clinical Pharmacology.

Pharmacokinetics and Dosage Adaptation of Meropenem during Continuous Venovenous Hemodiafiltration in Critically Ill Patients

T. Buclin, J. Biollaz, L. Decosterd, 2003, Journal of clinical pharmacology.

Determination of aciclovir and ganciclovir in human plasma by liquid chromatography-spectrofluorimetric detection and stability studies in blood samples.

T. Buclin, J. Biollaz, L. Decosterd, 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Influence of debrisoquin phenotype on the inducibility of propranolol metabolism

J. Biollaz, G. Wilkinson, A. Wood, 1989, Clinical pharmacology and therapeutics.

Meniere-like syndrome following epidural morphine analgesia.

J. Biollaz, A. Borgeat, S. Linder, 1989, Anesthesiology.

ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421".

J. Biollaz, H. Gavras, R. Davies, 1981, The Lancet.

Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein.

Nicolas Widmer, Serge Leyvraz, Bertrand Rochat, 2006, British journal of clinical pharmacology.

Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry.

A. Telenti, T. Buclin, J. Biollaz, 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Simultaneous determination of deoxyribonucleoside in the presence of ribonucleoside triphosphates in human carcinoma cells by high-performance liquid chromatography.

R. Mirimanoff, J. Biollaz, P. Coucke, 1999, Analytical biochemistry.

Renal Drug Transporters and Drug Interactions

T. Buclin, J. Biollaz, F. Livio, 2017, Clinical Pharmacokinetics.

Determination of Unbound Antiretroviral Drug Concentrations by a Modified Ultrafiltration Method Reveals High Variability in the Free Fraction

A. Telenti, T. Buclin, J. Biollaz, 2008, Therapeutic drug monitoring.

Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC-UV after solid-phase extraction.

A. Telenti, J. Biollaz, C. Marzolini, 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Valganciclovir in Adult Solid Organ Transplant Recipients

T. Buclin, J. Biollaz, L. Decosterd, 2009, Clinical pharmacokinetics.

Whole-blood pharmacokinetics and metabolic effects of the topical carbonic anhydrase inhibitor dorzolamide

A. Munafo, T. Buclin, J. Biollaz, 2004, European Journal of Clinical Pharmacology.

Determination of meropenem in plasma and filtrate-dialysate from patients under continuous veno-venous haemodiafiltration by SPE-LC.

T. Buclin, J. Biollaz, L. Decosterd, 2002, Journal of pharmaceutical and biomedical analysis.

[Risk of overtreatment: not to be neglected. The example of antiepileptic drugs].

M. Reichhart, T. Buclin, J. Biollaz, 2006, Revue medicale suisse.

Efavirenz Plasma Levels Can Predict Treatment Failure and Central Nervous System Side Effects in Hiv-1-infected Patients

A. Telenti, T. Buclin, J. Biollaz, 2022 .

Famotidine should be taken with supper : the effect of drug-meal interactions on gastric acidity and plasma famotidine levels

A. Blum, J. Biollaz, U. Klotz, 1991 .

Early evening nizatidine intake with a meal optimizes the antisecretory effect

A. Blum, J. Biollaz, D. Armstrong, 1993, Alimentary pharmacology & therapeutics.

Enprostil, in contrast to cimetidine, does not inhibit propranolol metabolism

J. Biollaz, C. Reilly, A. Wood, 1986, Clinical pharmacology and therapeutics.

Pharmacokinetics and Pharmacodynamics of IFN-β1a in Healthy Volunteers

Alain Munafo, Thierry Buclin, A. Munafo, 2000 .

Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients

Amalio Telenti, Hansjakob Furrer, Thierry Buclin, 2005, Pharmacogenetics and genomics.

Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection

Jacques Fellay, Amalio Telenti, Thierry Buclin, 2003, Clinical pharmacology and therapeutics.

Pharmacogenetics‐Based Population Pharmacokinetic Analysis of Efavirenz in HIV‐1‐Infected Individuals

A. Telenti, T. Buclin, J. Biollaz, 2009, Clinical pharmacology and therapeutics.

Free and Total Plasma Levels of Lopinavir during Pregnancy, at Delivery and Postpartum: Implications for Dosage Adjustments in Pregnant Women

A. Telenti, T. Buclin, J. Biollaz, 2012, Antiviral therapy.

Determination of lopinavir and nevirapine by high-performance liquid chromatography after solid-phase extraction: application for the assessment of their transplacental passage at delivery.

A. Telenti, T. Buclin, J. Biollaz, 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

928 Colombo

A. Telenti, T. Buclin, J. Biollaz, 2006 .

Cell disposition of raltegravir and newer antiretrovirals in HIV-infected patients: high inter-individual variability in raltegravir cellular penetration.

A. Telenti, T. Buclin, J. Biollaz, 2011, The Journal of antimicrobial chemotherapy.

Pregnancy outcome following maternal exposure to pregabalin may call for concern

V. Rousson, T. Buclin, J. Biollaz, 2016, Neurology.

Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability

T. Buclin, J. Biollaz, L. Decosterd, 2008, British Journal of Cancer.

Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein.

T. Buclin, J. Biollaz, L. Decosterd, 2006, British journal of clinical pharmacology.

Specific determination of PAH and its N-acetyl metabolite by HPLC increases the accuracy and precision of PAH clearance measurements.

T. Buclin, J. Biollaz, L. Decosterd, 1998, Renal failure.

High-performance liquid chromatography of the renal blood flow marker p-aminohippuric acid (PAH) and its metabolite N-acetyl PAH improves PAH clearance measurements.

T. Buclin, J. Biollaz, L. Decosterd, 1997, Journal of chromatography. B, Biomedical sciences and applications.

Four‐Hour Infusions of Synthetic Atrial Natriuretic Peptide in Normal Volunteers

J. Biollaz, F. Brunner‐Ferber, B. Waeber, 1986, Hypertension.

Blood pressure maintenance in awake dehydrated rats: renin, vasopressin, and sympathetic activity.

J. Biollaz, M. Burnier, H. Brunner, 1983, The American journal of physiology.

The Importance of Assessing the Dose Actually Administered in Pharmacokinetic Trials

T. Buclin, J. Biollaz, N. Perrottet, 2005, Clinical pharmacology and therapeutics.

Prevention of arrhythmias by flecainide after noncardiac thoracic surgery.

J. Biollaz, R. Chioléro, L. Kappenberger, 1989, The Annals of thoracic surgery.

Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers.

A. Munafo, T. Buclin, J. Biollaz, 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[Pharmacovigilance update].

T. Buclin, J. Biollaz, F. Livio, 2011, Revue medicale suisse.

Sinistrin Clearance for Determination of Glomerular Filtration Rate: A Reappraisal of Various Approaches Using a New Analytical Method

A. Munafo, T. Buclin, J. Biollaz, 1997, Journal of clinical pharmacology.

Three new long‐acting converting‐enzyme inhibitors: Relationship between plasma converting‐enzyme activity and response to angiotensin I

J. Biollaz, M. Burnier, H. Gavras, 1981, Clinical pharmacology and therapeutics.

[Pharmacovigilance and teratovigilance 2008].

J. Biollaz, F. Livio, A. Ivanyuk, 2009, Revue medicale suisse.

[Pharmacovigilance and teratovigilance].

T. Buclin, J. Biollaz, F. Livio, 2007, Revue medicale suisse.

Comparison of the efficacy and safety of two formulations of micronized progesterone (Ellios and Utrogestan) used as luteal phase support after in vitro fertilization.

J. Biollaz, P. Capelli, M. Germond, 2002, Fertility and sterility.

Influence of interferon β-1a dose frequency on PBMC cytokine secretion and biological effect markers

F. Spertini, A. Munafo, T. Buclin, 1999, Journal of Neuroimmunology.

Evaluation of the angiotensin challenge methodology for assessing the pharmacodynamic profile of antihypertensive drugs acting on the renin-angiotensin system.

T. Buclin, J. Biollaz, H. Brunner, 1999, British journal of clinical pharmacology.

Enalapril maleate and a lysine analogue (MK-521): disposition in man.

J. Biollaz, E. Ulm, T. Vassil, 1982, British journal of clinical pharmacology.

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.

J. Biollaz, H. Gavras, H. Brunner, 1981, British journal of clinical pharmacology.

Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.

J. Biollaz, E. Ulm, H R Brunner, 1982, British journal of clinical pharmacology.

Effects of the oral angiotensin-converting enzyme inhibitor MK-421 in human hypertension.

J. Biollaz, H. Gavras, R. Davies, 1981, Clinical science.

The effect of a low dose of quinidine on the disposition of flecainide in healthy volunteers

A. Munafo, T. Buclin, J. Biollaz, 2005, European Journal of Clinical Pharmacology.

Altered flecainide disposition in healthy volunteers taking quinine

A. Munafo, J. Biollaz, G. Reymond-Michel, 2004, European Journal of Clinical Pharmacology.

High-performance liquid chromatographic assay with fluorometric detection for flecainide and its major metabolites in urine and serum.

A. Munafo, J. Biollaz, 1989, Journal of chromatography.

Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and drug combinations.

J. Ménard, J. Biollaz, M. Burnier, 1990, Journal of hypertension.

Once-a-week azithromycin in AIDS patients: tolerability, kinetics, and effects on zidovudine disposition

A. Munafo, J. Biollaz, P. Dayer, 1992, Antimicrobial Agents and Chemotherapy.

Acute cardiovascular effects of two central phenylethanolamine-N-methyl-transferase inhibitors in unanesthetized desoxycorticosterone-salt hypertensive rats.

J. Biollaz, H. Gavras, I. Gavras, 1984, European Journal of Pharmacology.

Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect.

J. Biollaz, M. Burnier, H. Gavras, 1983, The Journal of pharmacology and experimental therapeutics.

Determination of the polyfructosan sinistrin in biological fluids by HPLC with electrochemical detection.

J. Biollaz, L. Decosterd, U. Kesselring, 1996, Journal of pharmaceutical and biomedical analysis.

Rate, type, and cost of adverse drug reactions in emergency department admissions.

T. Buclin, J. Biollaz, B. Yersin, 2001, European journal of internal medicine.

No renal dysfunction or salt and water retention in acute mountain sickness at 4,559 m among young resting males after passive ascent.

T. Buclin, J. Biollaz, L. Decosterd, 2020, Journal of applied physiology.

Trace lithium in mood disorders.

M. Preisig, T. Buclin, J. Biollaz, 1999, Journal of affective disorders.

Who is in charge of assessing therapeutic drug monitoring? The case of imatinib.

T. Buclin, J. Biollaz, L. Decosterd, 2011, The Lancet. Oncology.

Pharmacokinetic-pharmacodynamic relationships of three angiotensin II receptor antagonists in normal volunteers.

T. Buclin, J. Biollaz, M. Burnier, 1996, Kidney international. Supplement.

A preliminary evaluation of the discriminative power of the monoethylglycinexylidide formation test after intravenous and oral administration of lidocaine.

A. Munafo, T. Buclin, J. Biollaz, 2001, Transplantation proceedings.

Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction.

A. Telenti, J. Biollaz, C. Marzolini, 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Chronic Treatment of Hypertensive Patients with Converting Enzyme Inhibitors

J. Biollaz, B. Waeber, J. Nussberger, 1986, Journal of cardiovascular pharmacology.

Effects of neuropeptide Y on intrarenal hemodynamics, plasma renin activity and urinary sodium excretion in rats.

J. Biollaz, B. Waeber, J. Aubert, 1996, Nephron.

Blood Pressure Variability in Ambulatory Hypertensive Patients: Effect of β-Blocking Agents and/or Diuretics

J. Biollaz, B. Waeber, H. Brunner, 1984, Journal of cardiovascular pharmacology.

Pharmacodynamic response to interferon beta-1a administered subcutaneously one-a-week or three-times-a-week, over one month

Alain Munafo, Thierry Buclin, François Spertini, 1998 .

"Iatrogenicity cascade": Doing harm by treating harm?

T. Buclin, J. Biollaz, M. Zeitlinger, 2008, Wiener Medizinische Wochenschrift.

Letter to the editor response to the article of Luisa Lina Villa HPV prophylactic vaccination: the first years and what to expect from now, in press.

J. Biollaz, J. Spinosa, C. Riva, 2011, Cancer letters.

Pharmacokinetics of Boron Sulfhydryl (BSH) in Patients with Intracranial Tumours

H. Fankhauser, A. Munafo, J. Biollaz, 1992 .

Hemofiltration clearance of flecainide in a patient with acute renal failure

J. Biollaz, R. Chioléro, A. Borgeat, 2004, Intensive Care Medicine.

Population pharmacokinetics of fluconazole given for secondary prevention of oropharyngeal candidiasis in HIV-positive patients

T. Buclin, J. Biollaz, L. Decosterd, 2001, European Journal of Clinical Pharmacology.

Cimetidine inhibition of ethmozine metabolism

J. Biollaz, O. Shaheen, A. J. Wood, 1985, Clinical pharmacology and therapeutics.

Evaluation of noninvasive blood pressure recording by photoplethysmography in clinical studies using angiotensin challenges.

T. Buclin, J. Biollaz, H. Brunner, 1999, British journal of clinical pharmacology.

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

A. Telenti, T. Buclin, J. Biollaz, 2001, AIDS.

Population pharmacokinetics of imatinib and the role of α 1-acid glycoprotein

T. Buclin, J. Biollaz, L. Decosterd, 2006 .

Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extraction.

J. Biollaz, L. Decosterd, S. Leyvraz, 1995, Journal of chromatography. B, Biomedical applications.